Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction

The Pharmacogenomics Journal volume 13, pages 189–196 (2013)Cite this article

Subjects

Abstract

Erectile dysfunction (ED) is usually treated with sildenafil. Although genetic polymorphisms in the endothelial nitric oxide synthase (eNOS) gene may impair endogenous NO formation, there is little information about how eNOS polymorphisms and haplotypes affect the responses to sildenafil. We studied 118 patients; 63 patients had ED secondary to radical prostatectomy (PED) and 55 had organic, clinical ED. eNOS genotypes for three eNOS polymorphisms (T−786C, rs2070744; a variable number of tandem repeats (VNTR) in intron 4; and Glu298Asp, rs1799983) were determined, and eNOS haplotypes were estimated using PHASE 2.1. The clinical responses to sildenafil were evaluated and the patients were classified as good responders (GR) or poor responders (PR) when their changes in five-item version of International Index for Erectile Function questionnaire were above or below the median value. The TC/CC genotypes and the C allele for the T−786C polymorphism were more common in GR, compared with PR patients with PED. However, the 4b4a/4a4a genotypes and the 4a allele for the VNTR polymorphism in intron 4 were more common in GR, compared with PR patients with clinical ED. The C-4a-Glu haplotype was more common in GR than in PR patients with PED. Conversely, the T-4b-Asp haplotype was less common in GR than in PR patients with PED. No other significant differences were found. Our findings show evidence that eNOS polymorphisms affect the responses of PED and clinical ED patients to sildenafil.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McVary KT . Clinical practice. Erectile dysfunction. N Engl J Med 2007; 357: 2472–2481.

    Article  CAS  PubMed  Google Scholar 

  2. Solomon H, Man JW, Jackson G . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251–253.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kloner R . Erectile dysfunction and hypertension. Int J Impot Res 2007; 19: 296–302.

    Article  CAS  PubMed  Google Scholar 

  4. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A et al. Common grounds for erectile dysfunction and coronary artery disease. Curr Opin Urol 2004; 14: 361–365.

    Article  PubMed  Google Scholar 

  5. Mills JN, Barqawi A, Koul S, Koul H, Meacham RB . The molecular basis of erectile dysfunction: from bench to bedside. Rev Urol 2005; 7: 128–134.

    PubMed  PubMed Central  Google Scholar 

  6. Awad A, Alsaid B, Bessede T, Droupy S, Benoit G . Evolution in the concept of erection anatomy. Surg Radiol Anat 2011; 33: 301–312.

    Article  PubMed  Google Scholar 

  7. Marien T, Sankin A, Lepor H . Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. J Urol 2009; 181: 1817–1822.

    Article  PubMed  Google Scholar 

  8. Toda N, Ayajiki K, Okamura T . Nitric oxide and penile erectile function. Pharmacol Ther 2005; 106: 233–266.

    Article  CAS  PubMed  Google Scholar 

  9. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ . Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17–S37.

    Article  CAS  PubMed  Google Scholar 

  10. Ghofrani HA, Osterloh IH, Grimminger F . Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006; 5: 689–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Carson CC, Lue TF . Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005; 96: 257–280.

    Article  CAS  PubMed  Google Scholar 

  12. Sandner P, Hutter J, Tinel H, Ziegelbauer K, Bischoff E . PDE5 inhibitors beyond erectile dysfunction. Int J Impot Res 2007; 19: 533–543.

    Article  CAS  PubMed  Google Scholar 

  13. Metzger IF, Sertório JTC, Tanus-Santos JE . Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 2007; 43: 987–992.

    Article  CAS  PubMed  Google Scholar 

  14. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 2005; 15: 565–570.

    Article  CAS  PubMed  Google Scholar 

  15. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE . Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 2011; 11: 393–399.

    Article  CAS  PubMed  Google Scholar 

  16. Lee Y-C, Wu W-J, Liu C-C, Wang C-J, Li W-M, Huang C-H et al. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 2009; 6: 3158–3165.

    Article  CAS  PubMed  Google Scholar 

  17. Rosas-Vargas H, Coral-Vazquez RM, Tapia R, Borja JL, Salas RA, Salamanca F . Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J Androl 2004; 25: 728–732.

    Article  CAS  PubMed  Google Scholar 

  18. Safarinejad MR, Khoshdel A, Shekarchi B, Taghva A, Safarinejad S . Association of the T-786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with vasculogenic erectile dysfunction in Iranian subjects. BJU Int 2011; 107: 1994–2001.

    Article  CAS  PubMed  Google Scholar 

  19. Erol B, Bozdogan G, Akduman B, Dursun A, Bozdogan S, Onem K et al. eNOS gene intron 4 VNTR and exon 7-G894T polymorphisms in Turkish men with erectile dysfunction: a case control study. J Sex Med 2009; 6: 1423–1429.

    Article  CAS  PubMed  Google Scholar 

  20. Sinici I, Guven EO, Serefoglu E, Hayran M . T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population. Urology 2010; 75: 955–960.

    Article  PubMed  Google Scholar 

  21. Napoli C, Ignarro LJ . Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol 2007; 60: 341–344.

    Article  CAS  PubMed  Google Scholar 

  22. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE . Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006; 186: 428–432.

    Article  CAS  PubMed  Google Scholar 

  23. Sandrim VC, de Syllos RWC, Lisboa HRK, Tres GS, Tanus-Santos JE . Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 2006; 189: 241–246.

    Article  CAS  PubMed  Google Scholar 

  24. Sandrim VC, de Syllos RWC, Lisboa HRK, Tres GS, Tanus-Santos JE . Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 2007; 16: 348–355.

    Article  CAS  PubMed  Google Scholar 

  25. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE . eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 2006; 41: 1044–1049.

    Article  CAS  PubMed  Google Scholar 

  26. Lacchini R, Silva PS, Tanus-Santos JE . A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 2010; 106: 357–361.

    CAS  PubMed  Google Scholar 

  27. Peskircioglu L, Atac FB, Erdem SR, Deveci S, Verdi H, Ozkardes H . The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 2007; 19: 149–153.

    Article  CAS  PubMed  Google Scholar 

  28. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  PubMed  Google Scholar 

  29. Tanus-Santos JE, Desai M, Flockhart DA . Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001; 11: 719–725.

    Article  CAS  PubMed  Google Scholar 

  30. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a −786T-->C mutation associated with coronary spastic angina. Hum Mol Genet 2000; 9: 2629–2637.

    Article  CAS  PubMed  Google Scholar 

  31. Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Chen L et al. Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 2008; 19: 3997–4005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Joshi MS, Mineo C, Shaul PW, Bauer JA . Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 2007; 21: 2655–2663.

    Article  CAS  PubMed  Google Scholar 

  33. Podlasek CA, Gonzalez CM, Zelner DJ, Jiang HB, McKenna KE, McVary KT . Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int J Impot Res 2001; 13 (Suppl 5): S1–15.

    Article  PubMed  Google Scholar 

  34. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005; 12: 177–182.

    Article  CAS  PubMed  Google Scholar 

  35. Luizon MR, Izidoro-Toledo TC, Simoes AL, Tanus-Santos JE . Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 2009; 28: 329–334.

    Article  CAS  PubMed  Google Scholar 

  36. Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE . Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 2007; 193: 438–444.

    Article  CAS  PubMed  Google Scholar 

  37. Sandrim VC, Palei AC, Luizon MR, Izidoro-Toledo TC, Cavalli RC, Tanus-Santos JE . eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 2010; 10: 40–45.

    Article  CAS  PubMed  Google Scholar 

  38. Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE . Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol 2004; 498: 189–194.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Author information

Authors and Affiliations

  1. Department of Pharmacology, State University of Campinas, Campinas, Brazil

    J J Muniz

  2. Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil

    R Lacchini, T O Rinaldi & J E Tanus-Santos

  3. Department of Surgery and Anatomy, Faculty of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil

    Y T D A Nobre, A J Cologna & A C P Martins

Authors
  1. J J Muniz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Lacchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T O Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y T D A Nobre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A J Cologna
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A C P Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J E Tanus-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J E Tanus-Santos.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muniz, J., Lacchini, R., Rinaldi, T. et al. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. Pharmacogenomics J 13, 189–196 (2013). https://doi.org/10.1038/tpj.2011.49

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2011.49

Keywords

This article is cited by

Search

Advanced search

Quick links